Atlas Trials

Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

Clinical trial NCT01202786 · COMPLETED

Trial details

NCT number
NCT01202786
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Neoplasms, Unknown Primary
Start date
2010-05-01
Primary completion
2011-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.